![]() ![]() 239000003130 blood coagulation factor inhibitor Substances 0.000 abstract 1.239000003868 thrombin inhibitor Substances 0.000 abstract description 4.QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound S()(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 10.239000004480 active ingredient Substances 0.000 claims description 17.239000008194 pharmaceutical composition Substances 0.000 claims abstract description 3.239000012453 solvate Substances 0.000 claims abstract description 6.239000003795 chemical substances by application Substances 0.000 claims abstract description 6.150000003839 salts Chemical class 0.000 claims abstract description 20.239000011780 sodium chloride Substances 0.000 claims abstract description 21.150000001875 compounds Chemical class 0.000 claims abstract description 59.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Lilly Co Eli filed Critical Lilly Co Eli Publication of P元05009A1 publication Critical patent/P元05009A1/xx Publication of PL176448B1 publication Critical patent/PL176448B1/pl Links Shuman Original Assignee Lilly Co Eli Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents Nowe tripeptydy i środek farmaceutyczny Google Patents PL176448B1 - Nowe tripeptydy i środek farmaceutyczny PL176448B1 - Nowe tripeptydy i środek farmaceutyczny ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |